Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/76571
Title: A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population
Authors: Gane, E
Schwabe, C
Given, B
Schluep, T
Hamilton, J
Lai, CL
Locarnini, S
Lau, J
Ferrari, C
Gish, R
Issue Date: 2017
Publisher: Elsevier
Source: Journal of hepatology, 2017, v. 66, no. 1, suppl. S, THU-176, p. S265 (Meeting Abstract) How to cite?
Journal: Journal of hepatology 
Description: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands, Apr 19-23, 2017
URI: http://hdl.handle.net/10397/76571
ISSN: 0168-8278
EISSN: 1600-0641
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

WEB OF SCIENCETM
Citations

2
Last Week
0
Last month
Citations as of May 20, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.